Bliss GVS Pharma Ltd

NSE: BLISSGVS · BSE: 506197 · Pharmaceuticals & Biotechnology · 56 announcements

Share price: ₹655.00
Market cap: ₹6,968 Cr
Revenue (annual): ₹927.1 Cr
Net profit (annual): ₹129.1 Cr
P/E (TTM): 43.2×Sector 43.8×
Promoter holding: 50.07%+15.06% QoQ
FII holding: 5.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Employee Stock Options 3 Share Pledge 2 Promoter Reclassification 2 Board Meeting Date 2 Annual General Meeting 2 Regulatory Approval 1 Promoter Buying (Off-Market) 1 Other Announcement 1 Management Change 1 Legal & Regulatory 1 Financial Results 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

6 Nov 2026 16:27 IST BSE

Legal & Regulatory

Bliss GVS Pharma Legal & Regulatory

Bliss GVS Pharma was fined Rs. 1,80,000 (excluding GST) by BSE and NSE for failing to appoint a woman director. The fine has been paid to the regulators.

Value: ₹0.02 Cr
From: BSE Limited and National Stock Exchange of India Limited

Open announcement → Read the filing ↗